28.91
Schlusskurs vom Vortag:
$28.77
Offen:
$28.93
24-Stunden-Volumen:
231.44K
Relative Volume:
0.46
Marktkapitalisierung:
$1.17B
Einnahmen:
$384.90M
Nettoeinkommen (Verlust:
$-851.00K
KGV:
-1,445.50
EPS:
-0.02
Netto-Cashflow:
$12.83M
1W Leistung:
+5.43%
1M Leistung:
+23.71%
6M Leistung:
+6.25%
1J Leistung:
+24.61%
Artivion Inc Stock (AORT) Company Profile
Firmenname
Artivion Inc
Sektor
Branche
Telefon
(770) 419-3355
Adresse
1655 ROBERTS BOULEVARD N W, KENNESAW
Vergleichen Sie AORT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AORT
Artivion Inc
|
28.91 | 1.17B | 384.90M | -851.00K | 12.83M | -0.02 |
![]()
ABT
Abbott Laboratories
|
129.05 | 231.50B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.95 | 154.04B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
387.53 | 144.27B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
85.11 | 105.58B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
75.50 | 43.95B | 5.54B | 4.18B | 623.10M | 7.00 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
2022-09-27 | Bestätigt | Lake Street | Buy |
2022-08-08 | Eingeleitet | Lake Street | Buy |
2022-03-03 | Eingeleitet | Stifel | Buy |
Artivion Inc Aktie (AORT) Neueste Nachrichten
Top Executive Sells Thousands of Artivion Shares! - TipRanks
Artivion raises 2025 revenue guidance to $423M-$435M with focus on AMDS and On-X opportunities - MSN
Tower Research Capital LLC TRC Sells 1,608 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Raymond James Financial Inc. Buys Shares of 9,628 Artivion, Inc. (NYSE:AORT) - Defense World
1 Healthcare Stock with Exciting Potential and 2 to Avoid - FinancialContent
Stifel maintains Artivion stock Buy rating, $30 target amid growth By Investing.com - Investing.com Nigeria
Artivion, Inc. (NYSE:AORT) Receives $31.40 Consensus PT from Brokerages - Defense World
CryoLife Stock Soars to 52-Week High, Hits $30.62 - MSN
Artivion, Inc.'s (NYSE:AORT) 29% Jump Shows Its Popularity With Investors - simplywall.st
Artivion (NYSE:AORT) Raised to “Strong-Buy” at Citizens Jmp - Defense World
Artivion, Inc. (NYSE:AORT) Q1 2025 Earnings Call Transcript - MSN
Artivion revenue increases 2% to USD 99M in Q1 2025 - Medical Buyer
Artivion’s Earnings Call: Optimism Amid Challenges - TipRanks
ARTIVION, INC. SEC 10-Q Report - TradingView
Artivion (AORT) Maintains Market Outperform Rating by JMP Securi - GuruFocus
Artivion (AORT) Maintains Market Outperform Rating by JMP Securities | AORT Stock News - GuruFocus
JMP maintains Artivion stock Market Outperform, $33 target - Investing.com
JMP maintains Artivion stock Market Outperform, $33 target By Investing.com - Investing.com India
What Analysts Are Saying About Artivion Stock - Benzinga
Artivion, Inc.'s (NYSE:AORT) CEO Looks Like They Deserve Their Pay Packet - simplywall.st
Artivion (AORT) Receives Reiteration of 'Buy' Rating from Needha - GuruFocus
Artivion (AORT) Receives Reiteration of 'Buy' Rating from Needham | AORT Stock News - GuruFocus
Artivion Announces Presentation of New Clinical Data from NEXUS - GuruFocus
Stifel maintains Artivion stock Buy rating, $30 target amid growth - Investing.com
Artivion Inc. Reports Q1 2025 Financial Results - TipRanks
Artivion Inc (AORT) Q1 2025 Earnings Call Highlights: Strong Product Growth Amid Cybersecurity ... - Yahoo Finance
Artivion Inc (AORT) Q1 2025 Earnings Call Highlights: Strong Pro - GuruFocus
Artivion (AORT) Reports Q1 2025 Growth and Raises Full-Year Guid - GuruFocus
Artivion: Q1 Earnings Snapshot - MySA
Artivion Inc (AORT) Q1 2025 Earnings: EPS of $(0.01) Beats Estimate, Revenue Surpasses Expectations at $99 Million - GuruFocus
Earnings call transcript: Artivion Q1 2025 revenue misses forecast, stock rises - Investing.com
Artivion (AORT) Lags Q1 Earnings Estimates - Yahoo Finance
Artivion Q1 2025 slides: Revenue grows 4% as cyber incident recovery accelerates - Investing.com India
Artivion’s (NYSE:AORT) Q1: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Artivion (AORT) Raises Revenue Outlook for 2025 | AORT Stock New - GuruFocus
Artivion Reports First Quarter 2025 Financial Results | AORT Sto - GuruFocus
Artivion Q1 2025 slides: Revenue grows 4% as cyber incident recovery accelerates By Investing.com - Investing.com South Africa
Artivion earnings beat by $0.06, revenue fell short of estimates - Investing.com UK
Artivion Reports First Quarter 2025 Financial Results - Star Local Media
Artivion (AORT) Shares Promising Clinical Data from Nexus Triomp - GuruFocus
Artivion (AORT) Shares Promising Clinical Data from Nexus Triomphe Trial | AORT Stock News - GuruFocus
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting - goSkagit
Artivion (AORT) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Artivion (AORT) to Release Quarterly Earnings on Monday - Defense World
Artivion: Q4 Earnings Snapshot - Barchart.com
Artivion Inc (AORT) Q1 2025 Earnings Report Preview: What To Loo - GuruFocus
Wells Fargo & Company MN Buys 6,299 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (NYSE:AORT) rises 5.3% this week, taking three-year gains to 16% - simplywall.st
LPL Financial LLC Grows Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results | AORT Stock News - GuruFocus
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results - Kilgore News Herald
Finanzdaten der Artivion Inc-Aktie (AORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):